Paul Goodyer

7.3k total citations · 2 hit papers
137 papers, 5.0k citations indexed

About

Paul Goodyer is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Goodyer has authored 137 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 45 papers in Pediatrics, Perinatology and Child Health and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Goodyer's work include Renal and related cancers (49 papers), Biomedical Research and Pathophysiology (20 papers) and Amino Acid Enzymes and Metabolism (20 papers). Paul Goodyer is often cited by papers focused on Renal and related cancers (49 papers), Biomedical Research and Pathophysiology (20 papers) and Amino Acid Enzymes and Metabolism (20 papers). Paul Goodyer collaborates with scholars based in Canada, United States and New Zealand. Paul Goodyer's co-authors include Michael R. Eccles, Elena Torban, Alison Dziarmaga, Ronald Klein, Diana M. Iglesias, Sandra Donnelly, Michael Mauer, Alan R. Sinaiko, Samy Suissa and Bernard Zinman and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Paul Goodyer

133 papers receiving 4.9k citations

Hit Papers

A common molecular basis ... 1996 2026 2006 2016 1996 2009 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul Goodyer 2.8k 1.0k 957 899 609 137 5.0k
Hans J. Baelde 1.8k 0.6× 814 0.8× 1.5k 1.6× 582 0.6× 405 0.7× 160 5.8k
Fiona E. Karet 4.7k 1.7× 1.4k 1.4× 1.3k 1.4× 412 0.5× 318 0.5× 100 6.1k
Francesco Emma 2.4k 0.8× 812 0.8× 2.7k 2.8× 945 1.1× 1.5k 2.5× 184 6.3k
Emile de Heer 2.9k 1.0× 1.1k 1.1× 2.6k 2.7× 608 0.7× 927 1.5× 204 8.5k
Michel Le Hir 2.1k 0.7× 625 0.6× 1.2k 1.3× 328 0.4× 403 0.7× 87 5.0k
Rikke Nielsen 1.5k 0.5× 417 0.4× 1.2k 1.3× 322 0.4× 812 1.3× 68 4.1k
Patricia D. Wilson 5.0k 1.8× 1.0k 1.0× 688 0.7× 664 0.7× 1.4k 2.3× 179 8.3k
Jean‐Loup Bascands 1.9k 0.7× 420 0.4× 718 0.8× 486 0.5× 224 0.4× 155 4.7k
Maria Pia Rastaldi 2.6k 0.9× 890 0.9× 4.1k 4.2× 262 0.3× 871 1.4× 120 7.3k
Tammo Ostendorf 2.0k 0.7× 651 0.6× 2.0k 2.1× 187 0.2× 382 0.6× 98 5.1k

Countries citing papers authored by Paul Goodyer

Since Specialization
Citations

This map shows the geographic impact of Paul Goodyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Goodyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Goodyer more than expected).

Fields of papers citing papers by Paul Goodyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Goodyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Goodyer. The network helps show where Paul Goodyer may publish in the future.

Co-authorship network of co-authors of Paul Goodyer

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Goodyer. A scholar is included among the top collaborators of Paul Goodyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Goodyer. Paul Goodyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cybulsky, Andrey V., et al.. (2023). Transition From Pediatric to Adult Nephrology Care: Program Report of a Single-Center Experience. Canadian Journal of Kidney Health and Disease. 10. 1035147036–1035147036. 3 indexed citations
3.
Karner, Courtney M., et al.. (2019). Molecular determinants of WNT9b responsiveness in nephron progenitor cells. PLoS ONE. 14(4). e0215139–e0215139. 10 indexed citations
4.
Kitzler, Thomas M., et al.. (2018). Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome. Pediatric Nephrology. 33(10). 1741–1750. 8 indexed citations
5.
Iglesias, Diana M., Zhao Zhang, Rachel Corsini, et al.. (2011). T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease. Kidney International. 80(2). 146–153. 22 indexed citations
6.
Iglesias, Diana M., Nicolas Wentzensen, Marcus J. Moeller, et al.. (2011). Lineage Specification of Parietal Epithelial Cells Requires β-Catenin/Wnt Signaling. Journal of the American Society of Nephrology. 23(1). 63–72. 54 indexed citations
7.
Midgley, Julian, et al.. (2011). Natural history of adolescent-onset cystinosis. Pediatric Nephrology. 26(8). 1335–1337. 6 indexed citations
8.
Lakhal‐Chaieb, Lajmi, et al.. (2010). A human ALDH1A2 gene variant is associated with increased newborn kidney size and serum retinoic acid. Kidney International. 78(1). 96–102. 34 indexed citations
9.
Hueber, Pierre‐Alain, Paula J. Waters, Philip A. Clarke, Michael R. Eccles, & Paul Goodyer. (2006). PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Kidney International. 69(7). 1139–1145. 41 indexed citations
10.
Boutros, Marylise, et al.. (2005). Transient neonatal cystinuria. Kidney International. 67(2). 443–448. 18 indexed citations
11.
Yiu, Verna, Elaine Orrbine, Rhonda J. Rosychuk, et al.. (2004). The safety and use of short-acting nifedipine in hospitalized hypertensive children. Pediatric Nephrology. 19(6). 644–650. 24 indexed citations
12.
Leclerc, Daniel, Marylise Boutros, Qing Wu, et al.. (2002). SLC7A9 mutations in all three cystinuria subtypes. Kidney International. 62(5). 1550–1559. 38 indexed citations
13.
Lemmink, Henny H., Nine Knoers, Lothar Károlyi, et al.. (1998). Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney International. 54(3). 720–730. 133 indexed citations
14.
Hoopes, R R, Robert J. Reid, Gregory L. Braden, et al.. (1998). CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis. Kidney International. 54(3). 698–705. 46 indexed citations
15.
Yoshida, Tadashi, Toshiaki Monkawa, Harriet S. Tenenhouse, et al.. (1998). Two novel 1α-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I. Kidney International. 54(5). 1437–1443. 51 indexed citations
16.
Goodyer, Paul, et al.. (1998). Cystinuria subtype and the risk of nephrolithiasis. Kidney International. 54(1). 56–61. 63 indexed citations
17.
Heuvel, Lambert P.W.J. van den, Henny H. Lemmink, Patrick Niaudet, et al.. (1996). Mutational analyses in Gitelman syndrome. Journal of the American Society of Nephrology. 7. 1 indexed citations
18.
Zhang, Xiaoxiang, Rima Rozen, Matthias A. Hediger, Paul Goodyer, & Patrice Eydoux. (1994). Assignment of the Gene for Cystinuria (SLC3A1) to Human Chromosome 2p21 by Fluorescence in Situ Hybridization. Genomics. 24(2). 413–414. 29 indexed citations
19.
Robinson, B. H., et al.. (1986). Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia.. Journal of Clinical Investigation. 77(5). 1422–1427. 79 indexed citations
20.
Goodyer, Paul, et al.. (1978). Hypernatremia in seborrheic dermatitis. The Journal of Pediatrics. 93(1). 148–149. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026